Gordana Vunjak-Novakovic

Department of Biomedical Engineering, Columbia University, NY, NY, USA; Department of Medicine, Columbia University, NY, NY, USA.

50 publications 2022 – 2026 ORCID

What does Gordana Vunjak-Novakovic research?

Gordana Vunjak-Novakovic studies extracellular vesicles (EVs), which are small particles released by cells that can carry important biological information. Her research particularly targets diseases related to the heart, lungs, blood, and sleep. She investigates how EVs can be effectively engineered and produced to serve as innovative treatments. Despite their promising potential, she highlights the significant hurdles in ensuring that these vesicles are made with consistent quality and are safe for use in patients.

Key findings

  • Current methods for producing extracellular vesicles face significant challenges in quality and consistency, hindering their clinical use.
  • Extracellular vesicles show promise as effective therapies for various diseases affecting the heart, lungs, blood, and sleep.
  • Improvements in manufacturing techniques are crucial to making extracellular vesicles suitable for medical applications.

Frequently asked questions

Does Dr. Vunjak-Novakovic study heart diseases?
Yes, she researches extracellular vesicles as potential treatments for heart diseases.
What techniques has Dr. Vunjak-Novakovic researched?
She has focused on engineering and producing extracellular vesicles for medical use.
Is Dr. Vunjak-Novakovic's work relevant to patients with sleep disorders?
Yes, her research includes the potential application of extracellular vesicles in treating sleep diseases.
What challenges does Dr. Vunjak-Novakovic address in her research?
She addresses the challenges of producing extracellular vesicles at a clinical level with consistent quality.
How could Dr. Vunjak-Novakovic's research impact treatments for lung diseases?
Her study on extracellular vesicles could lead to new and effective therapies specifically targeting lung conditions.

Publications in plain English

Squidiff: predicting cellular development and responses to perturbations using a diffusion model.

2026

Nature methods

He S, Zhu Y, Tavakol DN, Ye H, Lao YH +9 more

Plain English
This study introduces Squidiff, a new tool that predicts how cells change and respond to different environments. Researchers found that Squidiff effectively maps these changes in various cell types, showing promise in applications like studying how blood vessels develop and how cells react to specific treatments. This matters because it can speed up the process of understanding diseases and developing new therapies. Who this helps: This benefits patients and doctors by providing insights that can lead to better treatment options.

PubMed

Avenues for optimization of cardiac therapeutics by minimally invasive delivery.

2026

Acta biomaterialia

Li Y, Menasché P, Vunjak-Novakovic G, Cheng K

Plain English
This research paper looked at new ways to deliver treatments for heart diseases without needing invasive surgeries. The authors found that methods like using blood vessels, specialized injections, or inhalation can directly target the heart and keep medications there longer, potentially leading to better outcomes for patients. However, challenges like the heart's movement and efficiency of drug delivery still need to be addressed to fully realize the benefits of these approaches. Who this helps: Patients with heart conditions seeking less invasive treatment options.

PubMed

Enhancing Cytoplasmic Expression of Exogenous mRNA Through Dynamic Mechanical Stimulation.

2025

Advanced healthcare materials

Chen J, Patel A, Mir M, Hudock MR, Pinezich MR +4 more

Plain English
This study looked at how to improve the delivery of mRNA using special lipid nanoparticles (LNPs) that are often used in vaccines, like those for COVID-19. Researchers found that using a mechanical vibration at a frequency of 65 Hz helped these particles escape from inside cells, making the delivery of mRNA more effective. After treatment, cell survival remained very high at 99.3%, showing that this method is safe and could lead to better gene therapies with fewer side effects. Who this helps: This benefits patients needing mRNA-based therapies and researchers working on new treatments.

PubMed

Cardiac fibroblast BAG3 regulates TGFBR2 signaling and fibrosis in dilated cardiomyopathy.

2025

The Journal of clinical investigation

Wang BZ, Morsink MA, Kim SW, Luo LJ, Zhang X +19 more

Plain English
This study looked at the role of a protein called BAG3 in heart cells, focusing on how its absence affects heart function and fibrosis in a condition known as dilated cardiomyopathy (DCM). Researchers found that when BAG3 is knocked out in heart fibroblasts, these cells become more sensitive to signals that promote fibrosis, leading to increased levels of TGFBR2, a key player in this fibrotic response. Specifically, in lab tests, these BAG3-deficient cells showed heightened fibrotic gene expression, indicating a significant link between BAG3 and heart disease. Who this helps: This helps patients with dilated cardiomyopathy and their doctors in understanding the disease better.

PubMed

Bioimpedance measurements of fibrotic and acutely injured lung tissues.

2025

Acta biomaterialia

Mir M, Chen J, Patel A, Pinezich MR, Hudock MR +6 more

Plain English
This study explored how injuries and diseases affect the electrical properties of lung tissues. Researchers examined lung tissues from rats and humans and found that healthy lung tissue had a bioimpedance (a measure of electrical resistance) of about 70.8 ohms, while fibrotic lung tissue had a significantly higher bioimpedance of 132.1 ohms. Understanding these changes can lead to quicker and more accurate diagnoses of lung conditions, which is crucial for better treatment outcomes. Who this helps: This helps patients with lung diseases and their doctors.

PubMed

ATAD2 Drives Prostate Cancer Progression to Metastasis.

2025

Molecular cancer research : MCR

Dutta A, Rodriguez-Calero A, Ronaldson-Bouchard K, Offermann A, Rahman D +9 more

Plain English
This research studied the role of a protein called ATAD2 in prostate cancer, particularly how it contributes to the spread of the disease to bones, which is a crucial factor in the severity of cancer and patient survival. The researchers found that higher levels of ATAD2 in prostate cancer were linked to more aggressive metastasis, and when they inhibited ATAD2 in lab tests, it slowed down cancer growth and spread significantly. This matters because targeting ATAD2 could lead to new treatments that improve outcomes for prostate cancer patients, especially those at risk of metastasis. Who this helps: Patients with advanced prostate cancer.

PubMed

Bioengineering solutions to improve women's health.

2025

Med (New York, N.Y.)

Klapperich CM, Vunjak-Novakovic G, Robinson J, Horton R, Kreeger PK +3 more

Plain English
This research paper discusses the need for innovative bioengineering solutions to improve women's health, focusing on diseases that affect women differently, such as reproductive issues and autoimmune diseases. It highlights promising tools like organoids and organ-on-chip systems to better understand these health problems and suggests that customized diagnostic and treatment strategies can lead to better health outcomes. These advancements are important because they aim to tackle longstanding issues in women's health effectively. Who this helps: This benefits patients, particularly women facing health challenges that are not adequately addressed by current treatments.

PubMed

The BAG3-HSP70-CHIP axis controls the degradation of TGFBR2 in cardiac fibroblasts.

2025

Journal of molecular and cellular cardiology

Morsink MAJ, Watkins JM, Zhu K, Zhang X, Luo LJ +3 more

Plain English
This study looked at how certain proteins in heart cells help control a receptor that can lead to heart tissue scarring, known as cardiac fibrosis. Researchers found that a protein called CHIP works with another protein, BAG3, to break down the receptor TGFBR2; when CHIP was more active, TGFBR2 broke down faster. This is important because it shows a potential new way to treat heart scarring by targeting this protein interaction. Who this helps: This benefits patients with heart conditions, especially those at risk for cardiac fibrosis.

PubMed

Geometrically controlled cardiac microtissues promote vascularization and reduce inflammationand.

2025

Cell biomaterials

Zhao Y, Khosravi R, Cheung K, Shen K, Wang Y +14 more

Plain English
This study looked at how specially shaped mini heart tissues, made from human stem cells, can improve heart repair by promoting blood vessel growth and reducing inflammation. The researchers found that these mini tissues, when implanted in rats, led to better integration with the body, increased blood vessel formation, and less cell death compared to spread-out cells. This matters because it shows a new way to enhance heart repair following damage, which could lead to better treatment options for patients with heart problems. Who this helps: This helps patients with heart conditions.

PubMed

OptoBarrier: An Optogenetic Platform for Modulating Endothelial Barriers In Vitro.

2025

ACS biomaterials science & engineering

Fleischer S, Liberman M, Summers M, Li V, Nash TR +1 more

Plain English
This study looked at a new tool called optoBarrier, which uses light to control how easily substances can pass through blood vessel walls in lab-grown tissues. The researchers found that by shining light on special cells, they could increase the permeability, or how "leaky," those blood vessel walls were, and they could adjust this effect based on how much light they used. This is important because it allows scientists to create more accurate models of human organs for testing drugs and understanding how diseases affect blood vessels. Who this helps: This helps researchers and drug developers in studying human health and diseases.

PubMed

Development of Nanocarrier-Based Oral Pegfilgrastim Formulations for Mitigating Hematopoietic Acute Radiation Syndrome.

2025

Advanced functional materials

Zhu Y, Tavakol DN, Wang H, He S, Ponnaiya B +13 more

Plain English
Researchers studied a new way to deliver a drug called pegfilgrastim to prevent severe blood problems caused by radiation exposure, known as hematopoietic acute radiation syndrome (H-ARS). They created tiny carriers using a special polymer that effectively delivered the drug, resulting in improved blood cell recovery in mice with radiation-related anemia. This advancement is important because it could help protect people from the harmful effects of radiation, whether in emergencies on Earth or during long space missions. Who this helps: This benefits patients at risk of radiation exposure, including astronauts and victims of nuclear accidents.

PubMed

Squidiff: Predicting cellular development and responses to perturbations using a diffusion model.

2025

bioRxiv : the preprint server for biology

He S, Zhu Y, Tavakol DN, Ye H, Lao YH +9 more

Plain English
This study introduced a new tool called Squidiff that helps scientists predict how individual cells develop and respond to different environmental changes, like treatments or injuries. Squidiff was tested on various cell types and proved effective in accurately predicting how cells react over time, which is crucial for understanding diseases and developing new drugs. The research showed that this model can quickly identify important changes in cell behavior, making it easier for scientists to generate new hypotheses for further studies. Who this helps: This benefits researchers and doctors looking for better ways to understand and treat diseases.

PubMed

A patient-specific engineered tissue model of BAG3-mediated cardiomyopathy.

2025

Journal of tissue engineering

Morsink MAJ, Wang BZ, Watkins JM, Zhuang RZ, Zhang X +5 more

Plain English
This study looked at a genetic heart disease caused by mutations in a gene called BAG3, which leads to weakened heart muscle and poor heart function. Researchers created a special lab-grown heart tissue model based on cells from a patient with this condition, showing that the tissue had disorganized structures and reduced ability to contract, mirroring the symptoms seen in patients. This work is important because it offers a new way to study this heart disease and test potential treatments more effectively than using animal models. Who this helps: This benefits patients with BAG3-related heart disease and their doctors by providing better tools to understand and treat their condition.

PubMed

Enhancing Paracellular Permeability of Airway Epithelium by Opening Tight Junctions via Osmo-Mechanical Stimulation.

2025

ACS biomaterials science & engineering

Patel A, Chen J, Mir M, Hudock MR, Pinezich MR +4 more

Plain English
This study explored how a combination of hypertonic saline (a salt solution) and mechanical vibrations can help open the tight junctions between airway cells in rats. The researchers found that this combination significantly increased the permeability of the airway epithelium, which could make it easier for drugs to be absorbed in the lungs. This matters because it offers a new and safe method to improve the delivery of medications directly to the lungs, potentially leading to better treatments for respiratory conditions. Who this helps: This benefits patients with respiratory diseases who need effective lung medication.

PubMed

Tumor-on-chip models of CAR-T cell therapy.

2025

Nature biotechnology

Vunjak-Novakovic G

PubMed

Integrating Hierarchical Vasculature into Engineered Cardiac Tissues.

2025

Advanced materials (Deerfield Beach, Fla.)

Zhuang RZ, Chesnais F, Vunjak-Novakovic G

Plain English
This study looked at how to better create engineered heart tissues that include blood vessels. Researchers found that there are two main ways to build these tissues: one that lets cells organize themselves naturally and another that uses specific engineering techniques to create the structure. Combining these approaches could improve the effectiveness of heart tissues for medical use, which is important for developing new treatments. Who this helps: This benefits patients with heart conditions by potentially leading to better tissue engineering solutions for heart repair.

PubMed

A custom preservation solution extends the ex vivo availability of living heart valves for transplantation.

2025

JTCVS open

Cordoves EM, Liu B, Pont O, LaSala VR, Daly GW +13 more

Plain English
This study looked at a new preservation solution designed to keep living heart valves usable for longer periods before transplantation. The researchers found that heart valves stored in this solution at normal temperature stayed viable for up to 7 weeks, while those kept in a standard storage solution maintained only limited viability for 1 to 2 weeks. This finding is significant because it could improve the availability of living heart valves for transplant, making surgeries safer and more efficient. Who this helps: This helps patients needing heart valve transplants.

PubMed

Airway-to-Go: An Ex Vivo Cystic Fibrosis Airway Model and Bioreactor System for High Throughput Gene Therapy Screening.

2025

ACS biomaterials science & engineering

Hudock MR, Daly GW, Rivas D, Patel A, Chen J +15 more

Plain English
This study developed a new model called Airway-to-Go to test potential gene therapies for cystic fibrosis (CF), a genetic disease that severely affects the lungs. Using both human and pig airway tissues, researchers created a system that better mimics CF lung conditions for up to 10 weeks and allows for real-time monitoring of how well gene therapies can be delivered and expressed. The findings showed that the model successfully highlighted differences in gene delivery, paving the way for more effective treatments in the future. Who this helps: This benefits patients with cystic fibrosis and the doctors treating them.

PubMed

Theranostic methodology for ex vivo donor lung rehabilitation.

2025

Med (New York, N.Y.)

Pinezich MR, O'Neill JD, Guenthart BA, Kim J, Vila OF +11 more

Plain English
This study looked at how to improve damaged donor lungs so they can be used for transplants. Researchers tested various methods on 23 lungs, including 17 that were injured, to develop a new approach combining therapy and diagnosis, which they called "theranostic." They found that using certain treatments allowed for real-time monitoring and improvements in lung function, with a focus on enhancing the viability of donor lungs that would otherwise be discarded. Who this helps: This benefits patients needing lung transplants and the doctors who provide their care.

PubMed

Human vascular organoids with a mosaicmutation recapitulate Proteus syndrome.

2024

bioRxiv : the preprint server for biology

He S, Zhu Y, Chauhan S, Tavakol DN, Lee JH +12 more

Plain English
This study focused on understanding Proteus syndrome, a condition that affects blood vessel formation. Researchers created a new model using human cells to mimic the unique blood vessel problems seen in this syndrome, finding that specific genetic changes led to smaller, but more interconnected, and functionally impaired blood vessels. Importantly, they discovered that using certain drugs could fix these issues, which points to new treatment options for patients with this rare condition. Who this helps: This helps patients with Proteus syndrome and their doctors.

PubMed

Grand Challenges at the Interface of Engineering and Medicine.

2024

IEEE open journal of engineering in medicine and biology

Subramaniam S, Akay M, Anastasio MA, Bailey V, Boas D +45 more

Plain English
Researchers from Johns Hopkins University and UC San Diego discussed major challenges in biomedical engineering at a workshop. They identified five key areas to focus on, including creating digital avatars of human health, developing smart devices to enhance bodily functions, and understanding brain function better. These advancements are important because they can lead to new technologies that improve patient care and treatment options. Who this helps: This benefits patients and healthcare providers.

PubMed

In vivo genome-wide CRISPR screening identifies CITED2 as a driver of prostate cancer bone metastasis.

2024

Oncogene

Arriaga JM, Ronaldson-Bouchard K, Picech F, Nunes de Almeida F, Afari S +3 more

Plain English
This study looked at the genetic factors that contribute to prostate cancer spreading to the bones, which is a major cause of death for these patients. Researchers found that the protein CITED2 plays a key role in this process and identified several new potential targets for treatments. Understanding these mechanisms could lead to better ways to prevent and treat bone metastasis in prostate cancer. Who this helps: Patients with prostate cancer and their doctors.

PubMed

An engineered human cardiac tissue model reveals contributions of systemic lupus erythematosus autoantibodies to myocardial injury.

2024

bioRxiv : the preprint server for biology

Fleischer S, Nash TR, Tamargo MA, Lock RI, Venturini G +15 more

Plain English
This study looked at how antibodies from patients with systemic lupus erythematosus (SLE) can damage heart tissue. Researchers found that in patients with severe heart inflammation, antibodies target dying heart cells, while in those with heart function issues, antibodies affected healthy heart cells. Understanding these differences helps doctors better predict heart problems in SLE patients and could lead to new treatments. Who this helps: This helps patients with systemic lupus erythematosus and their doctors.

PubMed

BeatProfiler: Multimodal In Vitro Analysis of Cardiac Function Enables Machine Learning Classification of Diseases and Drugs.

2024

IEEE open journal of engineering in medicine and biology

Kim Y, Wang K, Lock RI, Nash TR, Fleischer S +3 more

Plain English
The research focused on a new tool called BeatProfiler, designed to evaluate how heart cells function and respond to drugs more efficiently than current methods. The study found that BeatProfiler can analyze signals related to heart contractions and calcium handling with 98% accuracy when distinguishing between healthy and disease-affected heart cells, and it classified different cardiac drugs with 96% accuracy. This is important because it allows for faster and more reliable understanding of heart health and the effects of medications, ultimately leading to better treatment strategies. Who this helps: Patients with heart conditions, their doctors, and researchers studying cardiac diseases.

PubMed

Correction: In vivo genome-wide CRISPR screening identifies CITED2 as a driver of prostate cancer bone metastasis.

2024

Oncogene

Arriaga JM, Ronaldson-Bouchard K, Picech F, Nunes de Almeida F, Afari S +3 more

PubMed

Heart-on-a-Chip Model of Epicardial-Myocardial Interaction in Ischemia Reperfusion Injury.

2024

Advanced healthcare materials

Bannerman D, Pascual-Gil S, Wu Q, Fernandes I, Zhao Y +11 more

Plain English
Researchers created a heart-on-a-chip model that includes epicardial cells, which are important for heart function and healing. They found that in conditions simulating heart injury, these epicardial cells helped protect the heart tissue, leading to lower cell death and better function compared to models without these cells. Specifically, the epicardial cells migrated into the heart tissue and contributed to its repair, showing that their presence significantly impacts how the heart responds to damage. Who this helps: This research benefits patients with heart conditions and doctors who are looking for better treatment options.

PubMed

Macrophages enhance contractile force in iPSC-derived human engineered cardiac tissue.

2024

Cell reports

Lock RI, Graney PL, Tavakol DN, Nash TR, Kim Y +7 more

Plain English
Researchers studied how adding macrophages, a type of immune cell, to heart tissue created from stem cells affects the heart's ability to contract. They found that the presence of these macrophages increased the contractile force of the engineered heart tissue by influencing calcium signaling. This discovery is important because it highlights that immune cells play a key role in heart function, which could lead to better treatments for heart diseases. Who this helps: This helps patients with heart conditions and doctors involved in cardiac research.

PubMed

Enhancing Cytoplasmic Expression of Exogenous mRNA through Dynamic Mechanical Stimulation.

2024

bioRxiv : the preprint server for biology

Chen J, Patel A, Mir M, Hudock MR, Pinezich MR +4 more

Plain English
This study looked at how to improve the delivery of mRNA using tiny lipid nanoparticles (LNPs) by applying mechanical vibrations at a frequency of 65 Hz. The researchers found that this vibration made it easier for LNPs to escape from their cellular storage compartments, resulting in a 99.3% cell viability rate and significantly improved gene transfer efficiency. This improvement means that treatments using these nanoparticles could work better and have fewer side effects. Who this helps: This benefits patients receiving mRNA-based therapies and vaccines.

PubMed

Modeling the Effects of Protracted Cosmic Radiation in a Human Organ-on-Chip Platform.

2024

Advanced science (Weinheim, Baden-Wurttemberg, Germany)

Tavakol DN, Nash TR, Kim Y, Graney PL, Liberman M +13 more

Plain English
This study examined the effects of prolonged exposure to cosmic radiation, which is a major risk for astronauts traveling to the Moon and Mars. Researchers developed a model using a small, artificial human organ system that mimics how human tissues respond to this type of radiation. They found that long-term exposure resulted in more severe damage to tissues than short bursts of the same total radiation dose, specifically identifying 58 genes linked to this damage. Who this helps: This research benefits astronauts by providing insights into protecting their health during space missions.

PubMed

SARS-CoV-2 pathogenesis in an angiotensin II-induced heart-on-a-chip disease model and extracellular vesicle screening.

2024

Proceedings of the National Academy of Sciences of the United States of America

Wu Q, Rafatian N, Wagner KT, Blamer J, Smith J +23 more

Plain English
This study examined how the COVID-19 virus affects the heart, especially in people with existing heart conditions. Researchers created a tiny heart model to simulate these effects and found that when infected with the virus, hearts with preexisting damage showed worse functioning, with decreased force and increased inflammation. They also discovered that certain cells from healthy human tissue might help protect the heart by improving its function and reducing damage during infection. Who this helps: This research benefits patients with heart disease, particularly those at risk of complications from COVID-19.

PubMed

Extracellular Matrix Sulfation in the Tumor Microenvironment Stimulates Cancer Stemness and Invasiveness.

2024

Advanced science (Weinheim, Baden-Wurttemberg, Germany)

Kuşoğlu A, Örnek D, Dansık A, Uzun C, Nur Özkan S +19 more

Plain English
This research looked at how certain proteins in the lining of tumors affect cancer cells, particularly in lung cancer (specifically adenocarcinoma). The study found that a higher level of sulfated proteins in the tumor environment caused cancer cells to grow more aggressively and behave more like stem cells, which can lead to worse outcomes for patients. In tests using a special lab-created model, they found that this sulfation led to significant increases in cell growth and invasiveness. Who this helps: This benefits lung cancer patients and their doctors by providing insights into how certain tumor characteristics can lead to more aggressive cancer.

PubMed

Storage, preservation, and rehabilitation of living heart valves to treat congenital heart disease.

2024

Med (New York, N.Y.)

Cordoves EM, Ferrari G, Zorn E, Bacha E, Vunjak-Novakovic G +1 more

Plain English
This study looked at how to better store and restore living heart valves to help treat congenital heart disease. The researchers found that using living valves instead of synthetic ones could lead to more effective replacements that can grow and repair themselves, potentially reducing the number of surgeries needed. This matters because it offers a promising new option for patients who struggle with valve disease, improving their quality of life and outcomes. Who this helps: This helps patients with congenital heart disease who need heart valve replacements.

PubMed

An engineered human cardiac tissue model reveals contributions of systemic lupus erythematosus autoantibodies to myocardial injury.

2024

Nature cardiovascular research

Fleischer S, Nash TR, Tamargo MA, Lock RI, Venturini G +16 more

Plain English
This study looked at how certain antibodies from patients with systemic lupus erythematosus (SLE) can damage heart tissue. Researchers created human heart models and found that antibodies from patients with high heart inflammation were more likely to attach to dying heart cells, while those from patients with heart function issues connected better with healthy heart cells. The findings highlight specific antibodies that may harm the heart and could lead to better ways to assess risks and treat heart problems in people with SLE. Who this helps: This helps patients with systemic lupus erythematosus and their doctors.

PubMed

An engineered model of metastatic colonization of human bone marrow reveals breast cancer cell remodeling of the hematopoietic niche.

2024

Proceedings of the National Academy of Sciences of the United States of America

Baldassarri I, Tavakol DN, Graney PL, Chramiec AG, Hibshoosh H +1 more

Plain English
This study looked at how breast cancer cells, especially aggressive triple-negative breast cancer (TNBC), interact with human bone marrow. Researchers created a special model of human bone marrow to see how the environment affects cancer cell growth and how cancer affects blood cell production. They found that specific cells in the bone marrow significantly influence TNBC cell behavior and that cancer presence changes the development of blood cells; in particular, 60% of hematopoietic stem cells changed to support cancer growth. This research is important because understanding how breast cancer spreads can lead to better treatments for patients in remission. Who this helps: This research benefits breast cancer patients, especially those with triple-negative breast cancer.

PubMed

A Minimally Invasive Robotic Tissue Palpation Device.

2024

IEEE transactions on bio-medical engineering

Mir M, Chen J, Patel A, Pinezich MR, Guenthart BA +2 more

Plain English
Researchers developed a new robotic device that helps surgeons assess the stiffness of soft tissues during minimally invasive surgeries, making it easier to identify issues like tumors. In tests with tissues from pigs and rats, the device accurately measured tissue stiffness, successfully locating a tumor mimic that was 2 cm wide and 5 mm deep. This advancement is important because it allows surgeons to make better decisions during surgery, improving patient outcomes. Who this helps: This helps patients undergoing robotic surgery.

PubMed

Lung-Mimetic Hydrofoam Sealant to Treat Pulmonary Air Leak.

2024

Advanced healthcare materials

Pinezich MR, Mir M, Graney PL, Tavakol DN, Chen J +11 more

Plain English
Researchers studied a new type of sealant designed to fix lung air leaks, a common problem after lung surgery that affects up to 60% of patients. This new "lung-mimetic" hydrofoam sealant closely resembles lung tissue, allowing it to effectively seal air leaks in lab animal tests, restoring normal lung function. These findings are important because they provide a potential solution for a complication that traditionally lacks reliable treatment. Who this helps: This benefits patients recovering from lung surgery.

PubMed

Recovery of extracorporeal lungs using cross-circulation with injured recipient swine.

2024

The Journal of thoracic and cardiovascular surgery

Chen P, Van Hassel J, Pinezich MR, Diane M, Hudock MR +11 more

Plain English
This study looked at a new method to recover damaged donor lungs using a technique called cross-circulation with pigs that had lung injury. They found that after 24 hours of cross-circulation, the injured donor lungs showed a significant improvement in function, with oxygen levels increasing from 138 to 539 mm Hg. This is important because it could help address the shortage of healthy lungs for transplantation by allowing damaged lungs to be repaired before they are transplanted. Who this helps: This helps patients waiting for lung transplants.

PubMed

Opto-electromechanical quantification of epithelial barrier function in injured and healthy airway tissues.

2023

APL bioengineering

Chen J, Mir SM, Hudock MR, Pinezich MR, Chen P +3 more

Plain English
This study looked at how injuries to the airway lining affect its ability to protect the lungs. Researchers found that when the airway epithelium is injured, its functions, like clearing mucus and keeping the tissue tightly connected, get disrupted. Their analysis showed specific changes in the airway's behavior, which helps better understand these injuries and develop better ways to diagnose them. Who this helps: This benefits patients with respiratory issues and doctors treating airway injuries.

PubMed

Effect of mechanical unloading on genome-wide DNA methylation profile of the failing human heart.

2023

JCI insight

Liao X, Kennel PJ, Liu B, Nash TR, Zhuang RZ +9 more

Plain English
This study looked at how heart failure affects DNA changes in heart cells and if these changes can be reversed with a device called a left ventricular assist device (LVAD), which helps pump blood for patients. Researchers found 2,079 areas of DNA that were altered in patients with a certain type of heart failure and 261 in another type, but only 3.2% of these changes returned to normal after using the LVAD. Understanding these genetic changes is important because it suggests that simply using a mechanical device may not be enough to fully recover from heart failure, and we may need new treatments that can change these genetic patterns for long-term recovery. Who this helps: This research benefits patients with heart failure and their doctors by highlighting the need for more effective treatments.

PubMed

Emerging Imaging Modalities for Functional Assessment of Donor Lungs.

2023

Current opinion in biomedical engineering

Hudock MR, Pinezich MR, Mir M, Chen J, Bacchetta M +2 more

Plain English
This research looks at new ways to assess and improve donor lungs that are usually rejected for transplantation. It found that advanced imaging techniques can help doctors better evaluate lung function and identify potential ways to repair these lungs, which is crucial given the shortage of available donor organs. Using these methods could improve transplant success and save more lives. Who this helps: This helps patients in need of lung transplants.

PubMed

Designing Biocompatible Tissue Engineered Heart Valves In Situ: JACC Review Topic of the Week.

2023

Journal of the American College of Cardiology

Cordoves EM, Vunjak-Novakovic G, Kalfa DM

Plain English
This study focuses on creating new heart valves using tissue engineering that can naturally adapt and grow within a patient’s body. The researchers emphasize that these engineered valves could potentially replace current options, which often have limitations, by mimicking the body's natural valve functions. The goal is to design these valves in a way that they can seamlessly integrate and perform well in each individual, addressing challenges that have made it hard to bring these innovations into regular clinical use. Who this helps: This benefits patients with heart valve disease, particularly those looking for long-lasting treatment options.

PubMed

Engineered cardiac tissue model of restrictive cardiomyopathy for drug discovery.

2023

Cell reports. Medicine

Wang BZ, Nash TR, Zhang X, Rao J, Abriola L +16 more

Plain English
This research studied restrictive cardiomyopathy (RCM), a heart condition that causes the heart muscle to become stiff and not relax properly. The scientists found that a specific genetic change in a patient led to heart cells that struggled to relax and function correctly, showing poorer performance in both lab cultures and engineered heart tissues. They discovered that a drug called trequinsin can improve the relaxation of these faulty heart cells, indicating a possible new treatment for patients with this genetic variant. Who this helps: This helps patients with restrictive cardiomyopathy and their doctors by providing potential new treatment options.

PubMed

Directed differentiation of human iPSCs into mesenchymal lineages by optogenetic control of TGF-β signaling.

2023

Cell reports

Wu JY, Yeager K, Tavakol DN, Morsink M, Wang B +3 more

Plain English
This study looked at how to control the process of turning stem cells into specific types of cells, like those found in muscles and cartilage, using light. The researchers found that using light to activate a signaling pathway (TGF-β) helped to develop these cells effectively, with results similar to traditional methods, but with less damage to the cells. This matters because it provides a new way to create specialized cells for research and medical applications, which could lead to better treatments for conditions affecting muscles and cartilage. Who this helps: Patients needing regenerative therapies for injuries or degenerative diseases.

PubMed

Modeling and countering the effects of cosmic radiation using bioengineered human tissues.

2023

Biomaterials

Tavakol DN, Nash TR, Kim Y, He S, Fleischer S +12 more

Plain English
Researchers studied how cosmic radiation affects human tissues by using bioengineered models that mimic real human tissues. They found that high doses of radiation caused significant changes in gene expression related to heart and bone marrow tissues, indicating damage. This research is important because it helps develop better protective measures for astronauts during long space missions, potentially improving their safety and health. Who this helps: This helps astronauts and space agencies planning long-duration missions.

PubMed

Cellular plasticity of the bone marrow niche promotes hematopoietic stem cell regeneration.

2023

Nature genetics

Hirakawa H, Gao L, Tavakol DN, Vunjak-Novakovic G, Ding L

Plain English
This study examined how certain cells in the bone marrow, called adipocytes, help regenerate blood stem cells after damage. Researchers found that these adipocytes can change into different types of cells and are crucial for the recovery of blood stem cells after a treatment that destroys the bone marrow. Specifically, when researchers blocked a particular gene in these adipocytes, the regeneration process was severely disrupted, indicating that the ability of these cells to change form is essential for healing. Who this helps: This research benefits patients recovering from bone marrow damage, such as those undergoing chemotherapy.

PubMed

Engraftment and injury repair in regionally conditioned rat lungby lung progenitors derived from human pluripotent stem cells.

2023

bioRxiv : the preprint server for biology

Liu HY, Predella C, Chen YW, Wang J, Pezet M +7 more

Plain English
This study looked at how certain human stem cell-derived lung cells can help repair injury in rat lungs. Researchers found that these lung cells, called distal lung epithelial progenitors (DLEPs), not only helped create healthy lung cells but also shielded the lung from damage during a typical injury process. This research is important because it could lead to new treatments for people with lung diseases by using cell therapy to heal damaged lungs. Who this helps: This helps patients suffering from lung diseases.

PubMed

Sound-guided assessment and localization of pulmonary air leak.

2023

Bioengineering & translational medicine

Pinezich MR, Mir SM, Reimer JA, Kaslow SR, Chen J +5 more

Plain English
This study examined a new method to find and measure air leaks in the lungs after surgery by using sounds made when air escapes from damaged tissue. Researchers tested this technique in both rats and pigs and found that the sounds from air leaks can reveal how severe the leak is and where it is located, with an accuracy of about 1 centimeter. This method could help doctors better detect and treat lung air leaks during surgery, potentially improving patient outcomes. Who this helps: This helps patients undergoing lung surgery and their doctors.

PubMed

Tracheal stenosis and airway complications in the Coronavirus Disease-19 era.

2023

Annals of thoracic surgery short reports

Krishnan A, Guenthart BA, Choi A, Trope W, Berry GJ +7 more

Plain English
This research studied how to treat tracheal stenosis, a narrowing of the trachea, in patients who had severe COVID-19 and were intubated. Eight female patients with tracheal stenosis were treated, with 62.5% undergoing surgery to remove and reconstruct part of the trachea, and 80% of those patients were symptom-free six months later. The findings suggest that managing tracheal stenosis after COVID-19 is effective, and there are also less invasive options for those who might not be good candidates for surgery. Who this helps: This benefits patients recovering from severe COVID-19 who develop airway complications.

PubMed

Current challenges and future directions for engineering extracellular vesicles for heart, lung, blood and sleep diseases.

2023

Journal of extracellular vesicles

Li G, Chen T, Dahlman J, Eniola-Adefeso L, Ghiran IC +24 more

Plain English
This research paper examines the potential of tiny particles called extracellular vesicles (EVs) in treating diseases related to the heart, lungs, blood, and sleep. The study found that while these EVs could be effective therapies, current methods for producing them at a clinical level face significant challenges, such as understanding their production and ensuring their quality. The findings highlight the need for better techniques in manufacturing and testing EVs to make them suitable for medical use. Who this helps: This research benefits patients with heart, lung, blood, and sleep diseases by improving potential treatments.

PubMed

Voicing the need to consider sex-specific differences in research.

2022

Developmental cell

Miguel-Aliaga I, Vunjak-Novakovic G, Stephenson EJ, Gachon F, Milagre I +3 more

Plain English
This paper looks at how men and women may respond differently to diseases and treatments, highlighting the importance of studying these differences in research. Researchers emphasize that considering these sex-specific differences can lead to better understanding and treatment of various health issues, including metabolic and neurological diseases. This matters because it could improve health outcomes and personalize medical care for everyone. Who this helps: Patients and doctors.

PubMed

Publication data sourced from PubMed . Plain-English summaries generated by AI. Not medical advice.